MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 122 filers reported holding MYOKARDIA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,828,000 | – | 66,001 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 399,360 | $38,586,000 | 34.31% |
| Copernicus Capital Management, LLC | 57,000 | $5,507,000 | 6.04% |
| Foresite Capital Management IV, LLC | 126,492 | $12,222,000 | 5.95% |
| Casdin Capital, LLC | 870,000 | $84,059,000 | 4.98% |
| Avoro Capital Advisors LLC | 1,880,000 | $181,646,000 | 3.59% |
| RTW INVESTMENTS, LP | 936,931 | $90,526,000 | 2.55% |
| Cormorant Asset Management, LP | 600,000 | $57,972,000 | 2.21% |
| Perceptive Advisors | 1,395,017 | $134,787,000 | 2.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $6,372,000 | 2.12% |
| Grace Capital | 24,400 | $2,358,000 | 2.02% |